Dynavax Technologies Corp reports results for the quarter ended June 30 - Earnings Summary

Dynavax Technologies

08/08/2025 04:20

Dynavax Technologies Corp DVAX.OQ reported quarterly adjusted earnings of 14 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 8 cents.  The mean expectation of five analysts for the quarter was for earnings of 11 cents per share. Wall Street expected results to range from 5 cents to 14 cents per share.

Revenue rose 29.3% to $95.44 million from a year ago; analysts expected $86.66 million.

Dynavax Technologies Corp's reported EPS for the quarter was 14 cents​.

The company reported quarterly net income of $18.72 million.

Dynavax Technologies Corp shares had risen by 12.8% this quarter and lost 12.4% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 9.7% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Dynavax Technologies Corp is $25.00, about 55.8% above its last closing price of $11.06

This summary was machine generated from LSEG data August 8 at 03:20 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
0.11
0.14
Beat
Mar. 31 2025
0.04
0.01
Missed
Dec. 31 2024
0.04
0.05
Beat
Sep. 30 2024
0.11
0.12
Beat